Molecular Partners AG (MOLN) stock
MOLNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.09+0.00 (0.00%)
Close on Nov 11, 2026Market cap $124.76MP/E –Yield –
Molecular Partners enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Molecular Partners's enterprise value was $32.25M on Nov 11, 2026, against $38.26M a year earlier. Over the last 5 years it ranged from $21.54M to $701.63M, with a median of $80.12M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $32.25M | -28.4% |
| 2025 | Dec 31, 2025 | $45.04M | -47.0% |
| 2024 | Dec 31, 2024 | $84.95M | +33.1% |
| 2023 | Dec 29, 2023 | $63.80M | -18.9% |
| 2022 | Dec 30, 2022 | $78.70M | -80.9% |
| 2021 | Dec 31, 2021 | $412.83M | – |
See a number that looks wrong?